NASDAQ:PLUR Pluri (PLUR) Stock Price, News & Analysis $0.97 0.00 (-0.29%) As of 03:50 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Pluri Stock (NASDAQ:PLUR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pluri alerts:Sign Up Key Stats Today's Range$0.90▼$1.0650-Day Range$0.85▼$1.2752-Week Range$0.85▼$3.99Volume22,170 shsAverage Volume21,980 shsMarket Capitalization$13.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Pluri Ltd. is an Israel-based biotechnology company developing cell-based products and technologies. Its therapeutic research centers on PLX cells, derived from human placental tissue and expanded using the company’s cell-manufacturing platform. Pluri has investigated these cells for potential use in a range of medical conditions; its therapies remain in development. The company also applies its cell-expansion technology to areas beyond medicine, including food technology and agriculture, where it is exploring cell-based products and production methods. Pluri was formerly known as Pluristem Therapeutics and adopted its current name in 2022 to reflect its broader focus on cell-based technologies. The company is headquartered in Haifa, Israel.AI Generated. May Contain Errors. Read More Pluri Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScorePLUR MarketRank™: 1.13188167625 of 5 starsPluri scored higher than 23% of companies evaluated by MarketBeat, and ranked 770th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPluri has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePluri has only been the subject of 1 research reports in the past 90 days.Read more about Pluri's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Pluri is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Pluri is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.07% of the float of Pluri has been sold short.Short Interest Ratio / Days to CoverPluri has a short interest ratio ("days to cover") of 0.79, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pluri has recently increased by 265.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPluri does not currently pay a dividend.Dividend GrowthPluri does not have a long track record of dividend growth. News and Social Media2.9 / 5News SentimentN/A News SentimentPluri has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Pluri this week, compared to 1 article on an average week.MarketBeat Follows3 people have added Pluri to their MarketBeat watchlist in the last 30 days. Company Ownership3.8 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $1,250,001.00 in company stock, which represents 9.1309% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Pluri insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,250,001.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders43.16% of the stock of Pluri is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.59% of the stock of Pluri is held by institutions.Read more about Pluri's insider trading history. Receive PLUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PLUR Stock News HeadlinesPluri CEO Letter: Turning Our Cell Technology and Experience into Commercial OpportunityNovember 16, 2026 | markets.businessinsider.comPluri Adds ISO 9001 and ISO 13485 Certifications to Support PluriCDMO Commercial ExpansionNovember 9, 2026 | markets.businessinsider.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 20 at 1:00 AM | Porter & Company (Ad)Zeo ScientifiX licenses Pluri tech, restructures ownershipOctober 30, 2026 | tipranks.comPluri Inc. (PLUR) Discusses Commercialization Strategy, ZEO ScientifiX Transaction and Financial Flexibility TranscriptOctober 30, 2026 | seekingalpha.comInsider Buying: Pluri (NASDAQ:PLUR) Director Buys $1,250,001.00 in StockOctober 28, 2026 | insidertrades.comPluri Inc. and Zeo Scientifix, Inc. Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative MedicineOctober 27, 2026 | marketscreener.comMPluri to Host Investor Conference Calls to Discuss Updates and Strategic DevelopmentsOctober 27, 2026 | markets.businessinsider.comSee More Headlines PLUR Stock Analysis - Frequently Asked Questions How have PLUR shares performed this year? Pluri's stock was trading at $2.99 on January 1st, 2026. Since then, PLUR stock has decreased by 68.2% and is now trading at $0.9520. How were Pluri's earnings last quarter? Pluri Inc. (NASDAQ:PLUR) released its earnings results on Thursday, November, 12th. The company reported ($0.85) earnings per share for the quarter. The firm had revenue of $759 thousand for the quarter. When did Pluri's stock split? Pluri shares reverse split on the morning of Monday, April 1st 2024.The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Pluri? Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/12/2026Today11/20/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (12m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PLUR's financial health is in the Red zone, according to TradeSmith. PLUR has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:PLUR CIK1158780 Webpluri-biotech.com Phone+972747107171Fax972-74-710-8787Employees92Year Founded2001Profitability EPS (Trailing Twelve Months)($2.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.82 million Net Margins-1,943.87% Pretax Margin-2,373.82% Return on EquityN/A Return on Assets-106.56% Debt Debt-to-Equity RatioN/A Current Ratio0.27 Quick Ratio0.27 Sales & Book Value Annual Sales$1.02 million Price / Sales13.62 Cash FlowN/A Price / Cash FlowN/A Book Value($1.16) per share Price / Book-0.83Miscellaneous Outstanding Shares14,380,000Free Float8,171,000Market Cap$13.89 million OptionableNo Data Beta0.64 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:PLUR) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersAre Tesla and SpaceX Going Bankrupt?Tesla and SpaceX shares crashed right after Democrats took the House and the Senate in the midterm election. E...Brownstone Research | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pluri With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.